In the Zone

 $CGC – Canopy Growth Corp. 

 

Canopy Growth Corporation is a specialty generic drug manufacturer that’s in the cannabis industry. In 2014 it became the first cannabis company to be publicly traded in North America. Canopy Growth operates in Germany, Canada, the United Kingdom, and the United States. The company operates in two segments and has a long list of products that include, dried cannabis flowers, oils, capsules as well as concentrates.  

 

In September the company partnered with Martha Stewart and Marquee Brands to launch Martha Stewart CBD and Acreage Holdings to launch a new THC- Infused drink. In conjunction with its subsidiaries the company engages in sales, distribution, as well as production of cannabis for medical as well as recreational uses and is well on its way to becoming a cannabis power house.  

 

As the market came to a close on Friday the stock the day breaking even at $18.78 on upside volume of 4.49 million but was up 31.15% for the week as the general market moved lower. Going forward please keep (CGC) Canopy Growth Corp. on your watch list for a continued move to the upside.

  

By Marlin Rolle

 

Please note that all the stocks listed are not a buy recommendations; please do your own due diligence or get help from a professional before trading.